Soros Robert
10% owner at OBDC; 10% owner at EXAR CORP; 10% owner at MAP Pharmaceuticals, Inc.
- Sold, on record
- $91.5M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Apr 17, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- OBDCBlue Owl Capital Corp10% owner
- EXAR CORP10% owner
- MAP Pharmaceuticals, Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- OBDC5.2M shares
- EXAR CORP1.1M shares
- MAP Pharmaceuticals, Inc.706 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MAP Pharmaceuticals, Inc.Plan not statedMar 12, 2010 2010
Sold 706 shares at $16.11 ($11k)
Soros Robert, 10% owner
Sold 0% of holdings ($45.5M position)2.8M shares leftFirst sale on recordFiling
- 2 Form 4 sale EXAR CORPPlan not statedJul 30, 2013 +1236 days
Sold 1,100 shares at $12.91 ($14k)
Soros Robert, 10% owner
Sold 0% of holdings ($76.8M position)6M shares leftFirst sale on recordFiling
- 3 Form 4 sale EXAR CORPPlan not statedJan 22, 2014 +176 days
Sold 985,708 shares at $12.14 ($12M)
Soros Robert, 10% owner
Sold 16.6% of holdings ($72.2M position)5M shares leftFiling
- 4 Form 4 sale EXAR CORPPlan not statedMay 29, 2014 +127 days
Sold 64,165 shares at $10.96 ($703k)
Soros Robert, 10% owner
Sold 1.3% of holdings ($53.3M position)4.8M shares leftFiling
- 5 Form 4 sale OBDCUnusualApr 17, 2017 +1054 days
Sold 5.2M shares at $15.09 ($78.8M)
Soros Robert, 10% owner
Sold 91.7% of holdings ($86M position)472,598 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2017 | Apr 19, 2017 | OBDC | 10% owner | Form 4 sale | 5.2M | $78.8M | 91.7% | Unusual | SEC |
| May 29, 2014 | May 29, 2014 | EXAR CORP | 10% owner | Form 4 sale | 64,165 | $703k | 1.3% | Plan not stated | SEC |
| Jan 22, 2014 | Jan 24, 2014 | EXAR CORP | 10% owner | Form 4 sale | 985,708 | $12M | 16.6% | Plan not stated | SEC |
| Jul 30, 2013 | Aug 1, 2013 | EXAR CORP | 10% owner | Form 4 sale | 1,100 | $14k | 0.0% | Plan not stated | SEC |
| Mar 12, 2010 | Mar 16, 2010 | MAP Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 706 | $11k | 0.0% | Plan not stated | SEC |